Advertisement
U.S. markets close in 1 hour 56 minutes
  • S&P 500

    5,251.35
    +2.86 (+0.05%)
     
  • Dow 30

    39,785.14
    +25.06 (+0.06%)
     
  • Nasdaq

    16,369.75
    -29.77 (-0.18%)
     
  • Russell 2000

    2,125.18
    +10.83 (+0.51%)
     
  • Crude Oil

    82.97
    +1.62 (+1.99%)
     
  • Gold

    2,242.00
    +29.30 (+1.32%)
     
  • Silver

    24.98
    +0.22 (+0.90%)
     
  • EUR/USD

    1.0799
    -0.0030 (-0.28%)
     
  • 10-Yr Bond

    4.2040
    +0.0080 (+0.19%)
     
  • GBP/USD

    1.2626
    -0.0012 (-0.10%)
     
  • USD/JPY

    151.3840
    +0.1380 (+0.09%)
     
  • Bitcoin USD

    70,794.45
    +1,959.30 (+2.85%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Athenahealth Q3 Just A Little Worse Than Expected, Things Could Get Better From Here

Baird Equity Research maintains an Outperform rating for athenahealth, Inc (NASDAQ: ATHN) after the company reported earnings Thursday after the market close. Analyst Michael Gillmor thinks the third-quarter report was just slightly worse than feared, but the risk-reward is still favorable.

The company reported lower than expected revenue due to low utilization and hurricanes. Bookings were soft on weak buying activity, and athenahealth decided to lower its revenue guidance.

View more earnings on ATHN

There were also some positives: The company is implementing cost reductions faster than expected. The company expects to generate $100 to $115 million of cost savings in 2018. Its cost savings include rationalizing marketing spend, office closures, and a new organizational structure.

Gillmor explained that the stock has some technical support around current price level (see Gillmor's track record here). Even with the assumption of slower growth in 2018, the analyst believes the risk-reward is attractive around 11 to 14 times implied EBITDA potential. Athenahealth reduced revenue guidance to $1.2 to $1.22 billion from a range of $1.21 million to $1.25. Gilmore thinks the revenue growth in 2018 should be at least 10 percent higher.

See also: 32 Stocks Moving In Friday's Mid-Day Session

Latest Ratings for ATHN

Oct 2017

Baird

Maintains

Outperform

Oct 2017

Wells Fargo

Maintains

Outperform

Oct 2017

First Analysis

Upgrades

Underweight

Equal-Weight

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

See more from Benzinga

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement